CDER List of Licensed Biological Products with (1) Reference Product Exclusivity and (2) Biosimilarity or Interchangeability Evaluations to Date

First Page		Document Content
Cytokines Biology Biosimilar Interferon Peginterferon alfa-2a Ribavirin Biologic License Application Biologic Peginterferon alfa-2b Antivirals Pharmacology Medicine		CDER List of Licensed Biological Products with (1) Reference Product Exclusivity and (2) Biosimilarity or Interchangeability Evaluations to Date Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 419,14 KB Share Document on Facebook

	MEDICATION GUIDE VIEKIRA XR (vee-KEE-rah-XR) (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets for oral use Important: When taking VIEKIRA XR in combination with ribavirin, you should also rea DocID: 1sPr9 - View Document
	--------------------------------CONTRAINDICATIONS----------------------------- EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN DocID: 1qjt9 - View Document
	Microsoft PowerPoint - Poster EASL 08 IDU MD.ppt DocID: 1qd0f - View Document
	Journal of Antimicrobial Chemotherapy, Suppl. A, In-vivo activity of antivirals against exotic RNA viral infections Peter G. Canonico, Meir Kende, Bruno J. Luscri and John W. Huggins DocID: 1par8 - View Document
	State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai DocID: 1p7Zv - View Document